Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetes |
Vol/bind | 53 |
Sider (fra-til) | 1187-1194 |
Antal sider | 8 |
ISSN | 0012-1797 |
Status | Udgivet - 2004 |
One weeks treatment with the long acting GLP-1 derivative, NN2211, markedsly increases 24-h glycaemia, reduces endogenous glucose release and improves alfa- and beta-cell function in type 2 diabetes patients
Kirstine Bruun Degn, C.B. Juhl, J. Sturis, B. Jakobsen, V. Chandramouli, Jørgen Rungby, B.R. Landau, Schmitz O.